70%ISOPROPYL ALCOHOL

70%ISOPROPYL ALCOHOL was reported 3499 times

70%ISOPROPYL ALCOHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 120 0.5240
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY NEGATIVE 1 0.5000
2 CATHETER CULTURE 1 0.5000
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 268 0.4012
4 LUPUS VULGARIS 469 0.3722
5 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 169 0.3012
6 SWOLLEN JOINT COUNT 74 0.2960
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 537 0.2681
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 530 0.2555
9 SWOLLEN JOINT COUNT INCREASED 814 0.2550
10 RHEUMATIC FEVER 1112 0.2492
11 C-REACTIVE PROTEIN 224 0.2416
12 DISLOCATION OF VERTEBRA 516 0.2260
13 FACET JOINT SYNDROME 730 0.2240
14 X-RAY ABNORMAL 397 0.2218
15 HEPATIC ENZYME 32 0.2148
16 ACQUIRED PORPHYRIA 14 0.1972
17 RETINITIS 327 0.1891
18 DUODENAL ULCER PERFORATION 1364 0.1832
19 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1206 0.1682
20 RHEUMATOID FACTOR POSITIVE 963 0.1666
21 MUSCLE INJURY 1261 0.1520
22 PORPHYRIA ACUTE 214 0.1491
23 HELICOBACTER INFECTION 1468 0.1427
24 FOLLICULITIS 1438 0.1370
25 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 881 0.1355
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 3 0.1304
27 PERIPHERAL VENOUS DISEASE 518 0.1267
28 C-REACTIVE PROTEIN ABNORMAL 773 0.1204
29 PEMPHIGUS 1495 0.1195
30 HAND DEFORMITY 1472 0.1121
31 BONE EROSION 358 0.1011
32 CATHETER SITE PARAESTHESIA 1 0.1000
33 LABOUR AUGMENTATION 1 0.1000
34 SERONEGATIVE ARTHRITIS 106 0.0925
35 BREAST CANCER STAGE III 591 0.0912
36 PERICARDITIS 1454 0.0865
37 LIP DRY 728 0.0801
38 HYPERCHOLESTEROLAEMIA 750 0.0776
39 SYNOVITIS 1383 0.0766
40 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 8 0.0762
41 ONYCHOMADESIS 316 0.0752
42 GRIP STRENGTH DECREASED 662 0.0751
43 JOINT RANGE OF MOTION DECREASED 1004 0.0748
44 IRRITABLE BOWEL SYNDROME 1457 0.0679
45 GLOSSODYNIA 1490 0.0665
46 ONYCHOMYCOSIS 292 0.0665
47 WOUND INFECTION 706 0.0644
48 ICTERUS INDEX INCREASED 1 0.0625
49 HYPOCHOLESTEROLAEMIA 21 0.0595
50 SPINAL FUSION FRACTURE 1 0.0556
51 DRUG TOLERANCE DECREASED 156 0.0555
52 SWOLLEN JOINT COUNT ABNORMAL 1 0.0526
53 BURSITIS 633 0.0521
54 AUTOIMMUNE DISORDER 503 0.0516
55 WOUND 1429 0.0511
56 GAIT APRAXIA 2 0.0488
57 PUSTULAR PSORIASIS 167 0.0486
58 FIBROMYALGIA 1113 0.0457
59 WALKING AID USER 301 0.0456
60 IMPAIRED HEALING 1454 0.0442
61 MATERNAL EXPOSURE TIMING UNSPECIFIED 164 0.0436
62 SYSTEMIC LUPUS ERYTHEMATOSUS 1461 0.0411
63 LIVER INJURY 998 0.0406
64 FINGER DEFORMITY 195 0.0402
65 LIVE BIRTH 322 0.0385
66 EXOSTOSIS 349 0.0382
67 EYE INJURY 115 0.0378
68 BLEPHAROSPASM 238 0.0378
69 TYPE 2 DIABETES MELLITUS 1267 0.0376
70 LUPUS-LIKE SYNDROME 333 0.0367
71 TENDER JOINT COUNT 3 0.0357
72 ULCER HAEMORRHAGE 237 0.0350
73 RASH VESICULAR 166 0.0343
74 OBESITY 541 0.0339
75 PULMONARY FIBROSIS 649 0.0338
76 SCIATICA 539 0.0338
77 NAIL DISORDER 291 0.0332
78 CARDIAC MONITORING ABNORMAL 1 0.0323
79 OSMOLAR GAP INCREASED 3 0.0297
80 CONTRAINDICATED PRODUCT ADMINISTERED 900 0.0297
81 PSORIATIC ARTHROPATHY 1201 0.0296
82 FOOT DEFORMITY 307 0.0277
83 LOWER LIMB FRACTURE 531 0.0276
84 RED BLOOD CELL SEDIMENTATION RATE INCREASED 305 0.0275
85 LOWER RESPIRATORY TRACT INFECTION 1227 0.0270
86 PRESCRIBED OVERDOSE 491 0.0253
87 JOINT DISLOCATION 268 0.0253
88 HIP ARTHROPLASTY 386 0.0252
89 BREAST CANCER STAGE II 208 0.0250
90 PRODUCT LABEL CONFUSION 143 0.0245
91 OVERLAP SYNDROME 17 0.0243
92 SYNOVIAL FLUID ANALYSIS 2 0.0230
93 GAIT INABILITY 763 0.0228
94 BLISTER 1274 0.0227
95 ARTHROPATHY 1255 0.0226
96 INFUSION RELATED REACTION 1457 0.0220
97 BLOOD CHOLESTEROL INCREASED 1014 0.0217
98 ILL-DEFINED DISORDER 1276 0.0210
99 HEPATIC ENZYME INCREASED 1429 0.0209
100 STOMATITIS 1258 0.0207
101 GENERAL SYMPTOM 153 0.0204
102 CONGENITAL ANOMALY 155 0.0200
103 TISSUE RUPTURE 1 0.0200
104 BACK INJURY 215 0.0198
105 PRESCRIBED UNDERDOSE 390 0.0195
106 NIGHT SWEATS 617 0.0191
107 HEPATIC CIRRHOSIS 359 0.0191
108 DISCOMFORT 1164 0.0191
109 MYOSITIS 171 0.0190
110 INJURY 1335 0.0190
111 SPONDYLITIS 69 0.0190
112 THERAPEUTIC PRODUCT EFFECT DECREASED 824 0.0184
113 WHEEZING 1040 0.0175
114 OSTEOARTHRITIS 735 0.0173
115 SLEEP DISORDER 1212 0.0172
116 KNEE ARTHROPLASTY 356 0.0169
117 COELIAC DISEASE 163 0.0166
118 PERFORATION 13 0.0161
119 ROAD TRAFFIC ACCIDENT 666 0.0159
120 OEDEMA 851 0.0157
121 MOBILITY DECREASED 1109 0.0154
122 C-REACTIVE PROTEIN INCREASED 561 0.0154
123 ANTIPHOSPHOLIPID ANTIBODIES 3 0.0154
124 SLEEP DISORDER THERAPY 3 0.0152
125 APPLICATION SITE CELLULITIS 1 0.0149
126 DELIRIUM 516 0.0149
127 SWELLING 1385 0.0148
128 LIVER DISORDER 649 0.0146
129 LIVER FUNCTION TEST INCREASED 310 0.0144
130 SPINAL FUSION SURGERY 57 0.0140
131 INFLAMMATION 705 0.0136
132 NORMAL NEWBORN 74 0.0136
133 DISABILITY 257 0.0130
134 LUNG DISORDER 616 0.0126
135 ADVERSE REACTION 165 0.0124
136 JOINT SWELLING 1478 0.0122
137 RHEUMATOID ARTHRITIS 1379 0.0121
138 GASTROINTESTINAL DISORDER 1060 0.0118
139 MUSCULOSKELETAL PAIN 598 0.0114
140 JOINT STIFFNESS 296 0.0113
141 EAR INFECTION 300 0.0113
142 MUSCULOSKELETAL STIFFNESS 985 0.0112
143 TASTE DISORDER 225 0.0111
144 SYNOVIAL DISORDER 5 0.0110
145 DRUG-INDUCED LIVER INJURY 343 0.0109
146 GENERAL PHYSICAL HEALTH DETERIORATION 1256 0.0108
147 SINUSITIS 1109 0.0108
148 PREGNANCY 216 0.0108
149 CONTUSION 1035 0.0107
150 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 175 0.0103
151 BACK DISORDER 165 0.0101
152 INFUSION SITE REACTION 30 0.0100
153 DRUG INTOLERANCE 964 0.0100
154 MATERNAL EXPOSURE DURING PREGNANCY 849 0.0095
155 ANALGESIC THERAPY 3 0.0093
156 HYPERTROPHIC SCAR 1 0.0092
157 TREATMENT FAILURE 756 0.0091
158 DRY MOUTH 736 0.0091
159 BRACHIAL PLEXOPATHY 2 0.0090
160 TENOSYNOVITIS STENOSANS 5 0.0090
161 DRUG THERAPY 3 0.0088
162 BLOODY DISCHARGE 10 0.0087
163 THERAPY NON-RESPONDER 390 0.0087
164 INFECTION 1239 0.0086
165 CONFUSIONAL STATE 1367 0.0084
166 DYSPEPSIA 810 0.0082
167 EPILEPSY 251 0.0082
168 INTENTIONAL PRODUCT USE ISSUE 719 0.0082
169 WEIGHT FLUCTUATION 85 0.0081
170 AMNESIA 519 0.0080
171 FREQUENT BOWEL MOVEMENTS 213 0.0079
172 APPENDICOLITH 3 0.0078
173 HYPERSENSITIVITY 1429 0.0077
174 ABDOMINAL DISCOMFORT 1290 0.0077
175 PERIPHERAL SWELLING 1183 0.0077
176 OSTEOPOROSIS 314 0.0076
177 ILIAC ARTERY STENOSIS 1 0.0076
178 MIGRAINE 697 0.0073
179 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 124 0.0072
180 MYCETOMA MYCOTIC 1 0.0072
181 GASTROINTESTINAL STOMA OUTPUT DECREASED 1 0.0071
182 JOINT DESTRUCTION 11 0.0071
183 HYPOAESTHESIA 1043 0.0070
184 NASOPHARYNGITIS 1284 0.0070
185 HEPATITIS 177 0.0069
186 ALOPECIA 1324 0.0067
187 URTICARIA 1108 0.0066
188 NEUROSYPHILIS 1 0.0066
189 MEDICATION ERROR 346 0.0062
190 EXPOSURE DURING PREGNANCY 380 0.0061
191 WEIGHT INCREASED 1287 0.0057
192 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 268 0.0056
193 HYPERTENSION 1172 0.0055
194 MEMORY IMPAIRMENT 737 0.0054
195 SPONDYLOLYSIS 1 0.0053
196 HYPERTRANSAMINASAEMIA 37 0.0053
197 DEAFNESS PERMANENT 1 0.0051
198 DEATH NEONATAL 7 0.0050
199 RECTAL HAEMORRHAGE 215 0.0050
200 ASTHMA 565 0.0050
201 COLITIS ULCERATIVE 222 0.0050
202 STARVATION KETOACIDOSIS 1 0.0050
203 RESPIRATORY DISORDER 148 0.0049
204 LABORATORY TEST ABNORMAL 144 0.0049
205 NAIL OPERATION 2 0.0048
206 INTERNATIONAL NORMALISED RATIO FLUCTUATION 10 0.0048
207 ADVERSE EVENT 430 0.0047
208 OSTEORADIONECROSIS 1 0.0045
209 OEDEMA PERIPHERAL 537 0.0044
210 EAR PAIN 85 0.0044
211 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 298 0.0042
212 MUSCLE SPASTICITY 51 0.0041
213 WHITE BLOOD CELL COUNT INCREASED 159 0.0041
214 ABDOMINAL PAIN UPPER 852 0.0041
215 BREAST CANCER STAGE I 38 0.0041
216 MUSCULAR WEAKNESS 458 0.0040
217 ARTHRITIS 314 0.0040
218 CHEST PAIN 737 0.0040
219 INSOMNIA 1052 0.0039
220 VIBRATORY SENSE INCREASED 1 0.0039
221 STEROID WITHDRAWAL SYNDROME 4 0.0039
222 UPPER RESPIRATORY TRACT INFECTION 179 0.0039
223 RED BLOOD CELL SEDIMENTATION RATE DECREASED 1 0.0038
224 EXTRADURAL ABSCESS 3 0.0038
225 CONDITION AGGRAVATED 1146 0.0038
226 INJECTION SITE REACTION 253 0.0037
227 DAIRY INTOLERANCE 1 0.0036
228 PANCREATITIS 187 0.0035
229 NECK PAIN 197 0.0035
230 FLUID RETENTION 178 0.0035
231 PARAESTHESIA 534 0.0034
232 MUSCLE SPASMS 618 0.0034
233 PRODUCT USE ISSUE 625 0.0033
234 DECREASED APPETITE 769 0.0033
235 RASH 1440 0.0033
236 FEELING HOT 202 0.0033
237 RESPIRATORY FUME INHALATION DISORDER 1 0.0032
238 PYREXIA 1116 0.0032
239 ALLERGY TO CHEMICALS 4 0.0032
240 GAIT DISTURBANCE 607 0.0032
241 SCLERITIS 5 0.0031
242 GASTROOESOPHAGEAL REFLUX DISEASE 250 0.0031
243 ADVERSE DRUG REACTION 275 0.0031
244 DEPRESSION 692 0.0030
245 PRURITUS 1168 0.0030
246 LYME DISEASE 10 0.0030
247 ALCOHOL POISONING 8 0.0030
248 ARTHRALGIA 1220 0.0029
249 PAIN IN EXTREMITY 852 0.0029
250 PRODUCT USE IN UNAPPROVED INDICATION 705 0.0028
251 TRYPTASE INCREASED 2 0.0028
252 JOINT ARTHROPLASTY 5 0.0028
253 THERAPEUTIC RESPONSE DECREASED 167 0.0028
254 UNDERDOSE 199 0.0027
255 VISUAL IMPAIRMENT 328 0.0026
256 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
257 DRUG TOLERANCE 13 0.0026
258 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
259 PNEUMONIA 806 0.0025
260 DENTAL FISTULA 1 0.0024
261 PAIN 1431 0.0023
262 DIABETIC HYPEROSMOLAR COMA 1 0.0023
263 PSORIASIS 299 0.0023
264 BODY TEMPERATURE INCREASED 46 0.0023
265 DYSPNOEA 1266 0.0022
266 HEPATIC ENZYME DECREASED 1 0.0022
267 IRON DEFICIENCY 10 0.0022
268 GENERAL ANAESTHESIA 1 0.0022
269 VOMITING 1037 0.0022
270 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 5 0.0022
271 METAPLASIA 1 0.0021
272 BLOOD CHOLESTEROL 1 0.0021
273 OCULAR NEOPLASM 1 0.0021
274 ABDOMINAL DISTENSION 219 0.0021
275 MALAISE 885 0.0020
276 BRONCHITIS 148 0.0020
277 WEIGHT DECREASED 541 0.0019
278 TACHYCARDIA 171 0.0019
279 POLYARTHRITIS 10 0.0019
280 GASTRIC ANTRAL VASCULAR ECTASIA 1 0.0019
281 CUSHINGOID 6 0.0019
282 ANXIETY 529 0.0019
283 DUODENAL ULCER 13 0.0018
284 RHEUMATOID NODULE 5 0.0018
285 PLEURITIC PAIN 5 0.0018
286 APNOEIC ATTACK 1 0.0018
287 FATIGUE 1380 0.0018
288 RASH PRURITIC 96 0.0018
289 ABDOMINAL PAIN 405 0.0017
290 PALMAR ERYTHEMA 2 0.0017
291 CHEMICAL BURN 2 0.0017
292 CREPITATIONS 5 0.0017
293 DIAPHRAGMATIC PARALYSIS 1 0.0017
294 BRAIN DEATH 5 0.0016
295 HEADACHE 1012 0.0016
296 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
297 PRODUCT QUALITY ISSUE 218 0.0016
298 DIZZINESS 795 0.0016
299 INTERVERTEBRAL DISCITIS 3 0.0016
300 FOETAL EXPOSURE DURING PREGNANCY 129 0.0016
301 BACILLUS INFECTION 1 0.0016
302 ASTHENIA 588 0.0016
303 NEUROPATHIC ARTHROPATHY 1 0.0015
304 ANTINUCLEAR ANTIBODY POSITIVE 5 0.0015
305 POSTOPERATIVE ADHESION 1 0.0015
306 PROTEIN TOTAL INCREASED 4 0.0015
307 DIARRHOEA 920 0.0014
308 HYPERPHOSPHATAEMIA 3 0.0014
309 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
310 OFF LABEL USE 1177 0.0013
311 ARTERIAL INJURY 1 0.0013
312 NAUSEA 1053 0.0013
313 PREGNANCY AFTER POST COITAL CONTRACEPTION 3 0.0013
314 HOSPITALISATION 192 0.0012
315 CHEMICAL INJURY 1 0.0012
316 LEUKOPENIA 61 0.0012
317 CARDIAC STRESS TEST ABNORMAL 1 0.0012
318 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
319 INCORRECT PRODUCT ADMINISTRATION DURATION 25 0.0012
320 THROMBOCYTOPENIA 125 0.0011
321 PRIMARY SEQUESTRUM 1 0.0011
322 BLOOD PHOSPHORUS INCREASED 3 0.0011
323 SYNOVIAL CYST 5 0.0011
324 ULCER 17 0.0011
325 BUNDLE BRANCH BLOCK 1 0.0011
326 HEPATIC NECROSIS 4 0.0011
327 SACROILIITIS 2 0.0011
328 WOUND SECRETION 4 0.0010
329 MASTOIDITIS 1 0.0010
330 DUODENAL PERFORATION 1 0.0010
331 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
332 ABSCESS JAW 1 0.0010
333 RESPIRATORY TRACT INFECTION 25 0.0010
334 SPINAL DISORDER 9 0.0009
335 SINUSITIS BACTERIAL 1 0.0009
336 BURNS THIRD DEGREE 1 0.0009
337 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
338 VASCULAR CALCIFICATION 1 0.0009
339 ASPIRATION 10 0.0009
340 ADRENAL INSUFFICIENCY 11 0.0009
341 PERIRECTAL ABSCESS 1 0.0009
342 HALO VISION 1 0.0009
343 IMMUNODEFICIENCY 13 0.0009
344 CARBON DIOXIDE DECREASED 1 0.0009
345 DYSPLASIA 1 0.0008
346 DRUG INEFFECTIVE 1090 0.0008
347 PRODUCT PACKAGING CONFUSION 2 0.0008
348 MONOCYTE COUNT DECREASED 1 0.0008
349 EJECTION FRACTION ABNORMAL 1 0.0008
350 SECRETION DISCHARGE 10 0.0008
351 ADJUSTMENT DISORDER 1 0.0008
352 PLATELET COUNT INCREASED 10 0.0008
353 RESPIRATORY ACIDOSIS 3 0.0008
354 AREFLEXIA 2 0.0007
355 JOINT EFFUSION 5 0.0007
356 TENOSYNOVITIS 2 0.0007
357 SKIN ATROPHY 4 0.0007
358 HYPERTHERMIA MALIGNANT 1 0.0007
359 INFERTILITY 1 0.0007
360 MEAN CELL VOLUME DECREASED 1 0.0006
361 FALL 211 0.0006
362 INTERMITTENT CLAUDICATION 1 0.0006
363 SPINAL CORD DISORDER 1 0.0006
364 SKIN WOUND 1 0.0006
365 INTENTIONAL PRODUCT MISUSE 51 0.0006
366 HYPOPNOEA 2 0.0006
367 FORMICATION 4 0.0006
368 BURNS SECOND DEGREE 1 0.0006
369 TREATMENT NONCOMPLIANCE 31 0.0006
370 LIVER TRANSPLANT REJECTION 1 0.0006
371 NODULE 7 0.0005
372 FLANK PAIN 5 0.0005
373 OVERDOSE 115 0.0005
374 GUN SHOT WOUND 1 0.0005
375 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
376 BLOOD URIC ACID INCREASED 3 0.0005
377 ATELECTASIS 5 0.0005
378 SPINAL CORD COMPRESSION 2 0.0005
379 EMPYEMA 1 0.0005
380 OSTEOLYSIS 1 0.0005
381 ANAPHYLACTOID REACTION 2 0.0005
382 TENDERNESS 5 0.0005
383 ATRIAL TACHYCARDIA 1 0.0005
384 CATHETER SITE ERYTHEMA 1 0.0005
385 DEREALISATION 1 0.0005
386 JAW FRACTURE 1 0.0005
387 APPLICATION SITE SCAB 1 0.0005
388 PSEUDOMEMBRANOUS COLITIS 1 0.0004
389 INFECTIOUS MONONUCLEOSIS 1 0.0004
390 WRONG PRODUCT ADMINISTERED 3 0.0004
391 VASCULAR DEVICE INFECTION 2 0.0004
392 BREAKTHROUGH PAIN 1 0.0004
393 THERMAL BURN 3 0.0004
394 VOLVULUS 1 0.0004
395 GASTROINTESTINAL TOXICITY 2 0.0004
396 DERMAL CYST 1 0.0004
397 APPLICATION SITE BURN 2 0.0004
398 HYPOPHOSPHATAEMIA 3 0.0004
399 MULTIPLE DRUG OVERDOSE 2 0.0004
400 EYELID IRRITATION 1 0.0004
401 CHEMICAL BURN OF SKIN 1 0.0004
402 STAPHYLOCOCCAL INFECTION 13 0.0004
403 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
404 BLOOD CHLORIDE DECREASED 1 0.0004
405 ACTINIC KERATOSIS 1 0.0004
406 BLOOD LACTIC ACID INCREASED 2 0.0004
407 MYASTHENIA GRAVIS 3 0.0004
408 RED BLOOD CELL COUNT INCREASED 1 0.0004
409 MACULE 1 0.0004
410 ACCIDENTAL OVERDOSE 13 0.0004
411 VITAMIN B12 DECREASED 1 0.0003
412 LUMBAR SPINAL STENOSIS 1 0.0003
413 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
414 APPENDICITIS 3 0.0003
415 NO ADVERSE EVENT 58 0.0003
416 INFUSION SITE PRURITUS 1 0.0003
417 NON-CARDIAC CHEST PAIN 1 0.0003
418 HEPATOTOXICITY 7 0.0003
419 SUBSTANCE USE DISORDER 1 0.0003
420 VENTRICULAR HYPOKINESIA 1 0.0003
421 MULTIPLE DRUG OVERDOSE INTENTIONAL 1 0.0003
422 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
423 QUALITY OF LIFE DECREASED 4 0.0003
424 CLOSTRIDIAL INFECTION 1 0.0003
425 PRODUCT LABEL ISSUE 2 0.0003
426 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
427 APPLICATION SITE REACTION 2 0.0003
428 SKIN REACTION 4 0.0003
429 PULMONARY TOXICITY 2 0.0003
430 SINUS TACHYCARDIA 4 0.0003
431 VENTRICULAR FIBRILLATION 3 0.0003
432 CONJUNCTIVITIS 5 0.0003
433 HYDRONEPHROSIS 2 0.0003
434 PHOTOPHOBIA 5 0.0003
435 TROPONIN INCREASED 2 0.0003
436 BACK PAIN 61 0.0003
437 FEELING JITTERY 5 0.0003
438 HYPOKALAEMIA 12 0.0003
439 RHINOVIRUS INFECTION 1 0.0003
440 APNOEA 2 0.0003
441 MUSCLE DISORDER 2 0.0002
442 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
443 BRAIN OEDEMA 3 0.0002
444 ABSCESS LIMB 1 0.0002
445 INTERVERTEBRAL DISC DISORDER 1 0.0002
446 IMPAIRED WORK ABILITY 5 0.0002
447 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
448 ABNORMAL SENSATION IN EYE 1 0.0002
449 PHYSICAL DISABILITY 1 0.0002
450 CATHETERISATION CARDIAC 1 0.0002
451 MENINGITIS ASEPTIC 1 0.0002
452 ACUTE HEPATIC FAILURE 3 0.0002
453 ABDOMINAL HERNIA 1 0.0002
454 HAEMOGLOBIN INCREASED 1 0.0002
455 RESPIRATORY DISTRESS 6 0.0002
456 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
457 NEPHROGENIC ANAEMIA 1 0.0002
458 ARTHRITIS INFECTIVE 1 0.0002
459 DEATH 185 0.0002
460 ROSACEA 1 0.0002
461 DEFORMITY 2 0.0002
462 SUSPECTED SUICIDE 1 0.0002
463 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
464 CARDIOGENIC SHOCK 3 0.0002
465 PARAESTHESIA ORAL 3 0.0002
466 NEURALGIA 5 0.0002
467 INFLAMMATORY BOWEL DISEASE 2 0.0002
468 BREATH SOUNDS ABNORMAL 1 0.0002
469 DIABETIC NEUROPATHY 1 0.0002
470 HEPATIC ENZYME ABNORMAL 1 0.0002
471 HYPOTONIA 2 0.0002
472 KLEBSIELLA INFECTION 1 0.0002
473 VAGINAL DISCHARGE 2 0.0002
474 ENDOCARDITIS 1 0.0002
475 UNRESPONSIVE TO STIMULI 5 0.0002
476 SKIN ULCER 5 0.0002
477 POOR VENOUS ACCESS 2 0.0002
478 FOETAL DEATH 1 0.0002
479 MALABSORPTION 1 0.0002
480 APPLICATION SITE ERYTHEMA 5 0.0002
481 SENSITIVITY TO WEATHER CHANGE 1 0.0002
482 DEPRESSED MOOD 10 0.0002
483 METABOLIC ACIDOSIS 6 0.0002
484 ANAL FISTULA 1 0.0002
485 INTENTIONAL OVERDOSE 12 0.0002
486 BRUXISM 1 0.0002
487 MENTAL STATUS CHANGES 5 0.0002
488 SKIN INFECTION 2 0.0002
489 EXERCISE TOLERANCE DECREASED 1 0.0002
490 MULTI-ORGAN FAILURE 3 0.0002
491 MUSCLE TWITCHING 4 0.0002
492 RALES 1 0.0002
493 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 31 0.0002
494 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
495 DECREASED INTEREST 1 0.0002
496 ENERGY INCREASED 1 0.0002
497 BACTERAEMIA 2 0.0002
498 SYMPTOM RECURRENCE 1 0.0002
499 GANGRENE 1 0.0002
500 RESPIRATORY DEPRESSION 2 0.0002
501 DRUG ABUSER 1 0.0002
502 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
503 PIGMENTATION DISORDER 1 0.0002
504 BACTERIAL INFECTION 3 0.0002
505 HYPOCALCAEMIA 3 0.0002
506 FOREIGN BODY SENSATION IN EYES 1 0.0002
507 PROCTALGIA 1 0.0002
508 ANGINA UNSTABLE 1 0.0002
509 TENDON DISORDER 1 0.0002
510 MENINGITIS 1 0.0001
511 BLOOD TESTOSTERONE DECREASED 1 0.0001
512 PRODUCT PREPARATION ERROR 3 0.0001
513 CROHN'S DISEASE 1 0.0001
514 ECCHYMOSIS 1 0.0001
515 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
516 ONYCHOCLASIS 1 0.0001
517 LYMPHOEDEMA 1 0.0001
518 INTENTIONAL DRUG MISUSE 3 0.0001
519 RIGHT VENTRICULAR FAILURE 1 0.0001
520 PAPULE 1 0.0001
521 EYE PAIN 8 0.0001
522 DIVERTICULUM 1 0.0001
523 RED BLOOD CELL COUNT DECREASED 4 0.0001
524 TOXICITY TO VARIOUS AGENTS 23 0.0001
525 ASCITES 4 0.0001
526 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
527 PEMPHIGOID 1 0.0001
528 HAEMODYNAMIC INSTABILITY 1 0.0001
529 ACIDOSIS 1 0.0001
530 RENAL FAILURE CHRONIC 1 0.0001
531 HAEMOLYSIS 1 0.0001
532 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
533 OCULAR HYPERAEMIA 6 0.0001
534 RENAL CYST 1 0.0001
535 ATRIAL FLUTTER 1 0.0001
536 HAEMORRHAGE 13 0.0001
537 INTERSTITIAL LUNG DISEASE 6 0.0001
538 SUBSTANCE ABUSE 1 0.0001
539 DRY EYE 6 0.0001
540 LOSS OF CONSCIOUSNESS 15 0.0001
541 VITAMIN D DECREASED 1 0.0001
542 ANURIA 1 0.0001
543 NEOPLASM PROGRESSION 4 0.0001
544 SPINAL OSTEOARTHRITIS 1 0.0001
545 IMMUNOSUPPRESSION 1 0.0001
546 RESPIRATORY RATE INCREASED 1 0.0001
547 GASTROENTERITIS VIRAL 2 0.0001
548 OSTEOMYELITIS 2 0.0001
549 HYPOTENSION 22 0.0001
550 HIDRADENITIS 1 0.0001
551 IRON DEFICIENCY ANAEMIA 1 0.0001
552 DEEP VEIN THROMBOSIS 7 0.0001
553 BLOOD SODIUM DECREASED 2 0.0001
554 POISONING DELIBERATE 1 0.0001
555 NEOPLASM MALIGNANT 7 0.0001
556 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
557 EYE IRRITATION 6 0.0001
558 VITAMIN D DEFICIENCY 1 0.0001
559 RENAL TUBULAR NECROSIS 1 0.0001
560 BODY TEMPERATURE DECREASED 1 0.0001
561 BRAIN INJURY 1 0.0001
562 THROMBOSIS 8 0.0001
563 HYPOTHERMIA 1 0.0001
564 MOTOR DYSFUNCTION 1 0.0001
565 INITIAL INSOMNIA 1 0.0001
566 TEMPERATURE INTOLERANCE 1 0.0001
567 BONE DENSITY DECREASED 3 0.0001
568 JOINT INJURY 2 0.0001
569 BODY HEIGHT DECREASED 1 0.0001
570 SKIN LACERATION 1 0.0001
571 INJECTION SITE NODULE 1 0.0001
572 RASH MACULO-PAPULAR 2 0.0001
573 SCAB 1 0.0001
574 BLOOD IRON DECREASED 1 0.0001
575 HYPERLIPIDAEMIA 1 0.0001
576 PRESYNCOPE 2 0.0001
577 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
578 CARDIOMEGALY 1 0.0001
579 SEPSIS 9 0.0001
580 CYST 1 0.0001
581 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
582 APPLICATION SITE IRRITATION 1 0.0001
583 SWELLING FACE 5 0.0001
584 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
585 IMMUNE SYSTEM DISORDER 1 0.0001
586 SARS-COV-2 TEST POSITIVE 1 0.0001
587 THROAT TIGHTNESS 2 0.0001
588 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
589 PERIPHERAL COLDNESS 1 0.0001
590 RESPIRATORY ARREST 2 0.0001
591 COMPLETED SUICIDE 6 0.0001
592 MASS 1 0.0001
593 HYPONATRAEMIA 4 0.0001
594 LYMPHOPENIA 1 0.0001
595 PARALYSIS 1 0.0001
596 IMPAIRED QUALITY OF LIFE 1 0.0001
597 LETHARGY 4 0.0001
598 HYPERTHYROIDISM 1 0.0001
599 PULMONARY MASS 1 0.0001
600 HYPOAESTHESIA ORAL 1 0.0001
601 ECONOMIC PROBLEM 1 0.0001
602 DEVICE RELATED INFECTION 1 0.0001
603 LIMB DISCOMFORT 2 0.0001
604 MUSCULOSKELETAL CHEST PAIN 1 0.0001
605 BASAL CELL CARCINOMA 1 0.0001
606 PRODUCT USE COMPLAINT 1 0.0001
607 RESPIRATORY TRACT CONGESTION 1 0.0001
608 MOVEMENT DISORDER 2 0.0001
609 METASTASES TO BONE 1 0.0001
610 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
611 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
612 EXPIRED PRODUCT ADMINISTERED 2 0.0001
613 LIP SWELLING 2 0.0001
614 BLOOD UREA INCREASED 1 0.0001
615 SKIN EXFOLIATION 5 0.0001
616 GASTRIC DISORDER 2 0.0001
617 MUSCULOSKELETAL DISCOMFORT 1 0.0001
618 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
619 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
620 HEAD DISCOMFORT 1 0.0001
621 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
622 RESTLESS LEGS SYNDROME 1 0.0001
623 BONE DISORDER 1 0.0001
624 END STAGE RENAL DISEASE 1 0.0001
625 AGITATION 4 0.0001
626 ANAPHYLACTIC REACTION 3 0.0001
627 HEPATIC STEATOSIS 1 0.0001
628 FOOT FRACTURE 1 0.0001
629 GASTRIC ULCER 1 0.0001
630 DIABETES MELLITUS 4 0.0001
631 SLEEP APNOEA SYNDROME 1 0.0001
632 PRODUCT SUBSTITUTION ISSUE 3 0.0001
633 ACUTE RESPIRATORY FAILURE 1 0.0001
634 HERNIA 1 0.0001
635 DYSPHONIA 3 0.0001
636 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
637 KIDNEY INFECTION 1 0.0001
638 ABNORMAL BEHAVIOUR 2 0.0001
639 UPPER LIMB FRACTURE 1 0.0001
640 SPINAL FRACTURE 1 0.0000
641 RIB FRACTURE 1 0.0000
642 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
643 FAECES DISCOLOURED 1 0.0000
644 SEPTIC SHOCK 2 0.0000
645 PRODUCT DISPENSING ERROR 1 0.0000
646 PRODUCT PRESCRIBING ISSUE 1 0.0000
647 ACUTE KIDNEY INJURY 7 0.0000
648 TRANSAMINASES INCREASED 1 0.0000
649 SOMNOLENCE 9 0.0000
650 APPLICATION SITE PRURITUS 1 0.0000
651 SEIZURE 5 0.0000
652 PERICARDIAL EFFUSION 1 0.0000
653 PALPITATIONS 5 0.0000
654 COMA 2 0.0000
655 LOCALISED INFECTION 1 0.0000
656 MENTAL IMPAIRMENT 1 0.0000
657 OSTEONECROSIS OF JAW 1 0.0000
658 HEART RATE INCREASED 4 0.0000
659 PNEUMONIA ASPIRATION 1 0.0000
660 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
661 CHRONIC KIDNEY DISEASE 3 0.0000
662 HAEMATEMESIS 1 0.0000
663 DIPLOPIA 1 0.0000
664 GASTRITIS 1 0.0000
665 FEAR 1 0.0000
666 PALLOR 1 0.0000
667 DRUG ABUSE 3 0.0000
668 OXYGEN SATURATION DECREASED 2 0.0000
669 PAIN IN JAW 1 0.0000
670 MYALGIA 6 0.0000
671 INTENTIONAL DOSE OMISSION 1 0.0000
672 ERYTHEMA 7 0.0000
673 RENAL INJURY 1 0.0000
674 BLOOD POTASSIUM DECREASED 1 0.0000
675 PLEURAL EFFUSION 2 0.0000
676 EMOTIONAL DISORDER 1 0.0000
677 PULMONARY EMBOLISM 3 0.0000
678 CYSTITIS 1 0.0000
679 MOOD SWINGS 1 0.0000
680 HYPOTHYROIDISM 1 0.0000
681 LACTIC ACIDOSIS 1 0.0000
682 BLOOD CREATININE INCREASED 2 0.0000
683 RENAL FAILURE 4 0.0000
684 HAEMOGLOBIN DECREASED 3 0.0000
685 FEELING ABNORMAL 7 0.0000
686 BURNING SENSATION 2 0.0000
687 HYPERKALAEMIA 1 0.0000
688 HEART RATE DECREASED 1 0.0000
689 HYPOXIA 1 0.0000
690 SKIN BURNING SENSATION 2 0.0000
691 DYSURIA 1 0.0000
692 DYSPNOEA EXERTIONAL 1 0.0000
693 COLITIS 1 0.0000
694 BLOOD PRESSURE INCREASED 4 0.0000
695 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
696 DISORIENTATION 1 0.0000
697 CARDIAC FAILURE CONGESTIVE 2 0.0000
698 CARDIAC ARREST 2 0.0000
699 POLLAKIURIA 1 0.0000
700 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
701 RENAL FAILURE ACUTE 1 0.0000
702 CONSTIPATION 5 0.0000
703 PULMONARY OEDEMA 1 0.0000
704 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
705 TINNITUS 1 0.0000
706 SKIN DISCOLOURATION 1 0.0000
707 NEUROPATHY PERIPHERAL 2 0.0000
708 PRODUCTIVE COUGH 1 0.0000
709 BLOOD GLUCOSE DECREASED 1 0.0000
710 HYPOGLYCAEMIA 1 0.0000
711 ATRIAL FIBRILLATION 2 0.0000
712 CELLULITIS 1 0.0000
713 THERAPY CESSATION 1 0.0000
714 NERVOUSNESS 1 0.0000
715 HAEMATOCHEZIA 1 0.0000
716 HERPES ZOSTER 1 0.0000
717 SURGERY 1 0.0000
718 SUICIDE ATTEMPT 1 0.0000
719 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
720 ANAEMIA 3 0.0000
721 DEVICE DIFFICULT TO USE 1 0.0000
722 FEBRILE NEUTROPENIA 1 0.0000
723 BLOOD PRESSURE DECREASED 1 0.0000
724 INJECTION SITE PRURITUS 1 0.0000
725 RESPIRATORY FAILURE 1 0.0000
726 DYSGEUSIA 1 0.0000
727 HALLUCINATION 1 0.0000
728 UNEVALUABLE EVENT 1 0.0000
729 ACNE 1 0.0000
730 INJECTION SITE BRUISING 1 0.0000
731 TREMOR 2 0.0000
732 BALANCE DISORDER 1 0.0000
733 SUICIDAL IDEATION 1 0.0000
734 CARDIAC DISORDER 1 0.0000
735 DYSPHAGIA 1 0.0000
736 SYNCOPE 1 0.0000
737 CHEST DISCOMFORT 1 0.0000
738 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
739 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
740 CHILLS 1 0.0000
741 EMOTIONAL DISTRESS 1 0.0000
742 DEHYDRATION 1 0.0000
743 VISION BLURRED 1 0.0000
744 COUGH 2 0.0000
745 PRODUCT DOSE OMISSION ISSUE 2 0.0000
746 DRUG INTERACTION 1 0.0000
747 URINARY TRACT INFECTION 1 0.0000
748 MYOCARDIAL INFARCTION 1 0.0000
749 COVID-19 1 0.0000
750 BLOOD GLUCOSE INCREASED 1 0.0000
751 INCORRECT DOSE ADMINISTERED 1 0.0000
752 INJECTION SITE PAIN 1 0.0000